"
"
In the 2007 and 2014 ASCRS surveys,
vancomycin was the most commonly
selected antibiotic for intraocular use.
The precipitous decline in vancomycin's
popularity is undoubtedly due to the
newly reported association with
hemorrhagic occlusive retinal vasculitis
(HORV). Although HORV is extremely rare,
it is associated with severe vision loss
that is often bilateral.
It is also interesting that nearly 1/5
respondents are planning to initiate
intracameral antibiotic prophylaxis in
the coming year. That 19% of U.S.
respondents are planning to adopt IC
prophylaxis (despite the lack of an FDA
approved product) may reflect mounting
evidence in the literature to support the
efficacy of this measure.
David Chang, MD, advisor,
Cataract Clinical Committee
Inflammation/infection
11 • 2017 ASCRS Clinical Survey
